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Abstract
Background—Impaired qualitative and quantitative left ventricular rotational mechanics predict 
cardiac remodeling progression and prognosis after myocardial infarction. We investigated 
whether cardiac rotational mechanics can predict cardiac recovery in chronic advanced 
cardiomyopathy (CMP) patients.
Methods and Results—63 advanced chronic and dilated CMP patients undergoing 
implantation of left ventricular assist device (LVAD) were prospectively investigated using speckle 
tracking echocardiography. Acute heart failure patients were prospectively excluded. We evaluated 
left ventricular (LV) rotational mechanics [apical and basal LV twist, LV torsion] and 
deformational mechanics [circumferential (CS) and longitudinal strain (LS)] before LVAD 
implantation. Cardiac recovery post-LVAD implantation was defined as (i) final resulting LV 
ejection fraction (EF) {greater than or equal to} 40%, (ii) relative LVEF increase {greater than or 
equal to} 50%, (iii) relative LVESV decrease {greater than or equal to} 50% (all 3 required). 12 
patients fulfilled the criteria for cardiac recovery (Rec Group). The Rec Group had significantly 
less impaired pre-LVAD “Peak LV Torsion” compared to the Non-Rec Group. Notably, both 
groups had similarly reduced pre-LVAD LVEF. By receiver-operating characteristic curve analysis, 
pre-LVAD “Peak LV Torsion” of 0.35 degrees/cm had a 92% sensitivity and a 73% specificity in 
predicting cardiac recovery. Peak LV torsion before LVAD implantation was found to be an 
independent predictor of cardiac recovery following LVAD implantation [OR 0.65 per 0.1 
degrees/cm (0.49–0.87), p=0.014].
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Conclusions—LV rotational mechanics appear to be useful in selecting patients prone to cardiac 
recovery after mechanical unloading induced by LVADs. Future studies should investigate the 
utility of these markers in predicting durable cardiac recovery following the explantation of the 
cardiac assist device.
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Over the last decade, left ventricular assist devices (LVAD) have established their role in 
improving the quality and length of life in the advanced heart failure (HF) patient 1, 2. An 
exciting and promising observation of the mechanically unloaded failing heart through 
LVAD support, is the improvement of the cardiac function to the point that some of these 
advanced HF patients were able to be weaned from the mechanical support 3–9. While left 
ventricular ejection fraction (LVEF) during mechanical unloading is used to identify patients 
achieving myocardial recovery, it has showed no predictive value prior to LVAD 
implantation 10. The need for measurement of additional quantitative and qualitative indexes 
of the left ventricle systolic function, beyond EF is a consequence of its complex nature. 
Myocardial muscle has a helical orientation with the subendocardial fibers following a right-
handed orientation and the subepicardial fibers a left-handed orientation. This type of 
cardiac muscle orientation, during cardiac systole results in a wringing torsional deformation 
of the left ventricle 11, 12. Left ventricular torsion has been found to play a pivotal role in 
facilitating the homogenous distribution of myocardial forces during systole. Clinical studies 
in chronic heart failure patients have associated left ventricular rotational dynamics with the 
degree of remodeling and the extension of myocardial fibrosis 13, 14. In addition, left 
ventricular global longitudinal strain (GLS) has been correlated with the extent of 
myocardial fibrosis in patients with advanced heart failure 15, 16.
We hypothesized that the extent and type of myocardial dysfunction of patients with 
advanced chronic heart failure is heterogeneous and may be predictive of LVAD facilitated 
myocardial recovery. Specifically, we theorized that the degree and extent of abnormal 
torsional myocardial mechanics and the degree of the impairment of GLS could predict 
those patients who were most likely to achieve myocardial recovery during durable 
mechanical unloading.
Methods
The data, analytical methods, and study materials will not be made available to other 
researchers outside the University of Utah Hospital system. Researchers interested in the 
data, methods, or analysis can contact the corresponding author for more information.
We screened 220 patients with advanced chronic systolic heart failure who had a clinical 
indication for LVAD implantation (bridge to transplant / destination therapy / bridge to 
decision). The study was approved by our institutions’ Institutional Review Board and the 
patients provided the type of informed consent required by this approval. All patients had 
been diagnosed with chronic and dilated cardiomyopathy and end-stage heart failure 
(NYHA IV), despite optimal medical and device therapy. We included patients that fulfilled 
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all the following criteria: i) chronic heart failure, ii) adequate quality of two dimensional 
(2D) echocardiographic images that allowed the analysis of rotational mechanics prior to 
LVAD implantation, and iii) at least 3 months after LVAD implantation with serial 
echocardiograms of sufficient quality to assess LVEF. We excluded patients with acute 
systolic heart failure or patients with clinical or histologic evidence of acute myocarditis. We 
also excluded patients with atrial fibrillation at the time of echocardiographic analysis, 
unless the patient was on paced rhythm. Myocardial recovery (Rec Group) post-LVAD 
implantation was defined as (i) final LVEF ≥ 40%, (ii) relative increase in LVEF ≥ 50%, and 
(iii) relative left-ventricular end-systolic volume (LVESVi) decrease ≥ 50%. Patients who 
did not fulfill the above criteria constituted the no recovery group (Non-Rec Group).
We also included 15 subjects without known structural heart disease (Control Group), who 
were referred for an echocardiogram for atypical chest pain or palpitations without evidence 
for myocardial ischemia and other significant arrhythmia. We compared the deformational 
and rotational echocardiographic parameters of the advanced heart failure patients, before 
LVAD implantation, to those of the Control Group, to determine the degree of the 
impairment in our heart failure population. The study was approved by the institutional 
review board of the participating institutions.
Echocardiography
Study participants were imaged in the left lateral decubitus position with a commercially 
available systems (Phillips and GE machines) coupled with a 3.5 MHz (M4S) transducer and 
films were digitally stored in cine-loop format; analyses were subsequently performed 
offline.
Echocardiogram protocol—Surveillance for functional recovery was undertaken using a 
protocol developed and tested at the University of Utah 5. Conventional echocardiograms 
were performed within 2 weeks before LVAD implantation and 1, 2, 3, 4, 6, 9 and 12 months 
after implantation. Echocardiographic studies included complete 2D and Doppler 
examinations. Assessment of LV volumes and LVEF were performed using the apical 4- and 
2-chamber views. Right ventricular (RV) size was evaluated by means of RV dimension 
obtained at end-diastole from an RV-focused apical 4-chamber view (basal RV end-diastolic 
dimension). Doppler evaluation included the assessment of mitral inflow velocities. Mitral 
inflow parameters evaluated included early mitral inflow velocity (E-wave), late or atrial 
mitral inflow velocity (a-wave), and E-wave deceleration time (EDT). The LV sphericity 
index (LVSI) was calculated by dividing the LV maximal long-axis internal dimension by 
the maximal short-axis internal dimension at end-diastole. All measurements were 
performed in accordance with current American Society of Echocardiography guidelines 17.
Left ventricle rotational echocardiographic analysis—Syngo velocity vector 
imaging technology software (Siemens Medical Solutions, Inc., Mountain View, Calif.) was 
used offline to track endomyocardial motion in the pre-LVAD 2D–echocardiogram images. 
The apical (the smallest cavity achievable distally to the papillary muscles) and basal 
(identified by the mitral valve) short-axis images were used for velocity vector imaging 
analysis. After selecting the optimal cardiac cycle, the endomyocardial border was 
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delineated in a “click to point” approach. Following that the software automatically outlines 
6 segments per short axis view. Images that revealed poor tracking quality were excluded 
from further analysis. LV rotations at the basal or apical short-axis views were determined as 
average angular displacement of the 6 myocardial segments. The positive peak of apical LV 
rotation and negative peak of basal LV rotation were automatically measured. Data points 
depicting the basal and apical LV rotation were exported to Excel (Microsoft Corporation, 
Redmond, WA, USA) to calculate LV twist and torsion. Peak LV twist is defined as the 
maximal instantaneous difference between the apical and basal rotations. Peak LV torsion is 
defined as the peak LV twist magnitude normalized to LV length. All measurements are the 
averages derived from three cardiac cycles.
Deformational echocardiographic analysis
Longitudinal strain: Gray-scale 2D apical images of the LV (4-, 2-, and 3-chamber views) 
were obtained and peak longitudinal strain analysis of the LV was performed offline by 
manual tracing of the endomyocardial contour. For each view, longitudinal strain was 
calculated as an average of the six automatically generated myocardial segments. GLS was 
calculated as an average of all segments generated by VVI analysis of the 3 apical views.
Circumferential strain: Circumferential strain (CS) of the mid-LV was calculated using the 
short-axis view at the level of the papillary muscles. Peak CS was defined as the average CS 
of all 6 segments (generated as previously described) in the particular short-axis view. For 
GLS and CS, measurements were derived by the average corresponding values of three 
cardiac cycles. For rotational and deformational analysis, images were acquired at 60–80 
frames/sec.
Hemodynamics
Patients underwent right heart catheterization within 1 week preceding LVAD implantation, 
which included measurement of central venous pressure (CVP), pulmonary artery (PA) 
pressures, pulmonary capillary wedge pressure (PCWP), cardiac index (CI).
Intra-observer and inter-observer variability
Fifteen patients were randomly selected to assess the reproducibility of peak LV apical and 
basal LV twist. Bland-Altman analysis was performed to evaluate intra-observer and inter-
observer agreement by repeating the analysis 3 months later by the same observer and by a 
second independent observer. Intra-observer agreement was excellent. According to Bland-
Altman analysis, the mean difference ± 2 SD for peak LV rotational parameters was 0.09 
± 1.8°, 0.2 ± 3.5 % for CS and 0.1 ±2.2 % for longitudinal strain. Inter-observer agreement 
was also good. According to Bland-Altman analysis, the mean difference ± 2 SD for LV 
rotational parameters was 0.2 ± 4.2°, 1.7 ± 4.8% for CS and 1.5 ± 4.1% for longitudinal 
strain.
Statistics
Continuous variables are expressed as mean ± standard deviation (SD). Categorical variables 
are expressed as numbers and percentages. Independent sample t-test and χ2 square test 
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were used to compare the continuous and non-continuous characteristics of the heart failure 
and control subjects respectively, and also the baseline characteristics of the recovered and 
non-recovered heart failure patients. Univariate and multivariate linear regression analyses 
were performed to evaluate the relationship between peak LV torsion in the heart failure 
population and the following baseline variables: age, duration of heart failure symptoms, 
LVEF, peak CS, GLS, LVEDD, LVESVi, and LVEDVi. Univariate and multivariate binary 
regression analyses were performed to evaluate the association of peak LV torsion in the 
heart failure population with recovery after adjustment for the following baseline variables: 
age, duration of heart failure symptoms, LVEF, CS, GLS, LVEDD, LVESVi, and LVEDVi. 
Receiver-operator-characteristics curve analysis was performed to determine the accuracy of 
baseline peak LV torsion to predict myocardial recovery following LVAD implantation. A p 
value < 0.05 is considered significant.
Results
Out of 220 patients implanted with LVAD, 63 patients met our inclusion criteria, of which 
12 fulfilled the criteria of myocardial recovery. Patients excluded from the study group 
included (Figure 1): 67 patients with inadequate quality of images and 90 patients with less 
than 3-month follow-up post LVAD implantation (which is inadequate period of time to 
assess the effect of LVAD-induced mechanical unloading on cardiac recovery) (5). We 
compared the baseline characteristics of the excluded patients to those included in the 
analysis in order to address selection biases and we revealed no significant differences 
(comparisons were done separately between those with and without myocardial recovery).
Clinical and echocardiographic characteristics of normal controls and heart failure 
patients
Compared to the control subjects, chronic systolic HF patients (before LVAD implantation) 
had significantly lower LVEF and LV rotational and deformational characteristics (Table 1). 
Furthermore, HF patients had significantly more impaired GLS and CS parameters (Table 
1).
Parameters affecting left ventricle torsion before LVAD implantation
Univariate linear regression analysis revealed significant association of various parameters 
with peak LV torsion: HF duration, CS, GLS and LVEDD (Table 2). In linear regression 
analyses predicting peak LV torsion, a two-variable model adjusting for peak CS (β= 
−0.057, p=0.001) showed LVEDD was an independent predictor (β= −0.221, p=0.002), as 
did a two-variable model entering global GLS (β= −0.076, p=0.001) and LVEDD (β= 
−0.181, p=0.029). Modeling HF duration, peak CS, and GLS together with LVEDD (Table 
2) had a similar result (LVEDD β= −0.164, p=0.029).
Characteristics of patients with myocardial recovery
Twelve patients (11 with non-ischemic and 1 with ischemic cardiomyopathy) fulfilled the 
criteria for myocardial recovery (Rec Group) (table 3), while 51 patients did not fulfill the 
criteria for myocardial recovery. The baseline characteristics of the Rec and Non-Rec Group 
are shown in Tables 4, 5 and 6. The Rec Group had significantly shorter duration of HF 
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compared to the Non-Rec group. Additionally, the Rec Group had significantly lower age, 
higher peak LV torsion and higher CI values before LVAD implantation (Tables 4 and 6, 
figure 2). Due to the small number of cardiac recovery cases, multivariate logistic regression 
analyses included only up to two explanatory variables. In such models, peak LV torsion was 
associated with recovery when adjusted for HF duration, cardiac index, or age (Table 7). No 
other variables were associated with recovery in two-variable models with peak LV torsion, 
which also was unaffected by those other variables and it remained significant in those 
models.
In the Rec Group, peak LVEF was achieved within the first 12 months following LVAD 
implantation, while in the Non-Rec Group the LVEF remained stable throughout the follow-
up period (Figure 3). Interestingly, LVEF did not differ significantly between the Rec and 
Non-Rec Group before LVAD implantation. Figure 4 shows the correlation between baseline 
torsion (before LVAD implantation) with the maximum achieved LVEF under LVAD 
support. By receiver-operator-characteristics (Figure 5), peak LV torsion ≥ 0.35 °/cm had a 
sensitivity of 92% and a specificity of 73% to predict myocardial recovery following LVAD 
implantation.
Following LVAD implantation, there were no significant differences in the anti-remodeling 
medical therapy between the Rec Group and Non-Rec Group: b-blocker (83% vs 67%, 
p=0.26), angiotensin converting enzyme inhibitor/angiotensin II receptor antagonist (83% vs 
56%, p=0.08) and aldosterone receptor antagonist (62 % vs 51%, p=0.55) respectively.
Discussion
In patients with chronic advanced systolic HF, LV torsion before LVAD implantation was 
found to predict myocardial recovery following mechanical unloading with a LVAD (Figure 
6). It is noteworthy that patients who experienced myocardial recovery following LVAD 
implantation, had before LVAD implantation LVEF similar to those who did not show post 
LVAD myocardial recovery (Figure 6). This is also consistent with prior observations studies 
(5, 7, 9, 10).
Previous studies have identified as independent predictors for myocardial recovery the 
young age and non-ischemic etiology 9, 18, 19. In concordance to those findings, our study 
also revealed that there was trend for younger and non-ischemic patients to reveal 
myocardial recovery. Additionally, in our Rec Group of patients, the time from the HF 
diagnosis to the implantation of the LVAD was significantly shorter compared to the Non-
Rec Group of patients. Previous studies also have identified a prognostic role of cardiac 
deformational and rotational parameters in heart failure patients undergoing cardiac 
resynchronization therapy 20. To our knowledge, this is the first study describing the role of 
LV torsional mechanics as a predictor for myocardial recovery following mechanical support 
with a LVAD.
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Impact of LV systolic dysfunction on LV torsional and deformational parameters in heart 
failure patients
In a normal heart, LV systole is associated with counterclockwise rotation at the apex, while 
the base rotates clockwise (when viewed from the apex), resulting in a twisting motion of 
the heart 11. Furthermore, myocardial energy efficiency is thought to be dependent on LV 
twist by normalizing the fiber shortening of the endomyocardial and epimyocardial layers 
during contraction 21, 22. Forty percent of the total stroke volume is produced by these 
twisting forces 23 and not reflected in the LVEF, a relatively crude assessment of LV 
function.
Clinical studies have shown that in patients with dilated cardiomyopathy, LV twist 
mechanisms are impaired 24 and predictive of outcome. When we compared the rotational 
parameters of our HF patients before LVAD implantation to patients without structural heart 
disease, we observed similar results. The occurrence of progressive LV dilatation with 
concomitant increase in LV sphericity index and widening of the LV apex results in the 
development of a more transverse myocardial fiber direction that ultimately results in 
impaired LV rotation 25, 26. In our HF study population, both patients who recovered and 
those that did not experience myocardial recovery had comparable LV sphericity indexes. 
This finding implies that beyond myocardial architecture disruption and consequent LV 
remodeling, more extensive myocardial injury as reflected in more abnormal rotational 
mechanics is more sensitive in predicting post-LVAD recovery. Importantly, LV torsion was 
related to the duration of HF which likely also reflects the magnitude and extent of 
irreversible myocardial injury.
In our pilot study we were unable to identify a correlation between baseline LVEF and 
baseline LV rotation parameters. Previous studies in HF patients have identified a correlation 
between LVEF and LV torsion, and this correlation was weaker in non-ischemic compared 
to ischemic patients 27. It should be noted that the patient population of our study is 
characterized by more advanced heart disease as compared to those studies. Half of our 
patients were inotrope dependent, had lower LVEF, and larger LV chamber volumes 
compared to the aforementioned clinical studies. LV torsion and LVEF are not identical 
parameters and studies have shown that LV torsion can provide additional information 
regarding ventricular systolic performance.
Role of left ventricular rotational and deformational mechanics in predicting myocardial 
recovery
In the current study, LV torsion before LVAD implantation was the only independent 
parameter that correlated with the maximum LVEF following LVAD implantation, 
predicting myocardial recovery (tables 4, 5 and 6). Impaired quantitative and qualitative LV 
rotational parameters in HF patients, have been associated with more advanced stages of 
heart disease 13, 14. In a group of HF patients with non-ischemic cardiomyopathy, those with 
reversed apical rotation correlated with more extensive remodeling and more advanced heart 
failure stages 13. Similarly, in our study the Non-Rec Group of patients had higher rates of 
abnormal direction of apical or basal rotation prior to LVAD implantation. The prognostic 
role of LV torsion has been studied in heart failure patients undergoing cardiac 
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resynchronization therapy (CRT) 27. Immediately following CRT implantation, patients with 
improvement in LV torsion predicted LV reverse remodeling six months later.
A prognostic role for LV torsion has also been found in patients following an acute 
myocardial infarction (AMI). In that study decreased LV torsion immediately following MI 
predicted adverse LV remodeling after 6 months 28. A preserved CS in post – MI patients 
has also been found to predict a favorable outcome and consistent with less LV remodeling 
29, 30
.
In HF patients, deformational LV parameters have also been identified as a prognostic tool. 
For example, worsening in GLS independently predicted long-term adverse events 31. In 
contrast, CS and GLS in our study was not associated with myocardial recovery. However, 
our patients had likely developed extensive LV remodeling at the time of LV mechanical 
unloading. This might indicate that as heart failure and LV remodeling evolves, left ventricle 
torsion constitutes the last effective contractile mechanism of the failing heart.
Rotational and deformational parameters of left ventricular function could provide 
significant prognostic information. In an era of imbalance between heart donation and 
demand, rotational mechanics could be a guidance tool for patient selection with a higher 
likelihood for myocardial recovery. This could have significant implications more 
specifically in young patients, where the protentional implantation of the LVAD in earlier 
stages of heart failure could enhance the changes for myocardial recovery. These strategies 
warrant future prospective clinical investigations.
Cardiac rotational /deformational mechanics and myocardial recovery in ischemic vs non-
ischemic cardiomyopathy
In our study of 20 patients with ischemic cardiomyopathy, only 1 revealed myocardial 
recovery following LVAD implantation. This is consistent with our recently reported study 
which revealed that LVAD-associated unloading resulted in a substantial improvement in 
myocardial structure, and systolic and diastolic function in 1 in 20 ischemic cardiomyopathy 
patients and 1 in 5 non-ischemic cardiomyopathy patients 32. Previous studies have also 
shown that myocardial recovery is significantly less common in patients with ischemic 
cardiomyopathy compared to the patients with non-ischemic cardiomyopathy. In our study, 
when we compared torsional values of the 19 patients with ischemic cardiomyopathy who 
had no myocardial recovery with those of patients with non-ischemic cardiomyopathy who 
had no myocardial recovery, we detected no significant difference.
Study limitations
Because of the well-identified challenges of imaging patients with LVAD devices, there was 
a large proportion of our patient population with poor quality echo images following LVAD 
implantation that we were unable to quantify torsional parameters on. For this reason, it is 
unclear whether the improvement in LVEF in LVAD patients is accompanied by concomitant 
improvement in torsional parameters. Transesophageal echocardiography could bypass the 
obstacle of poor imaging quality in LVAD patients with recovered myocardium 33. 
Nonetheless, this piece of information could provide additional criteria for potential LVAD 
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explantation and potentially minimizing the risk of heart failure recurrence. We were 
however able to acquire short axis (SAX) basal images (to calculate basal rotation) and SAX 
images at the mid-level of the LV (for the calculation of the CS) in many of our patients. 
This data is provided in Supplemental Materials (Online Table 1, Online Figure 1). 
Regardless, the lack of this information does not invalidate the role of LV torsion as a 
predictor of myocardial recovery following LV mechanical unloading.
Additionally, the number of patients that fulfilled the criteria for myocardial recovery is 
relatively small. However, in the two-variable model, LV torsion was still the parameter 
associated with myocardial recovery. Future prospective studies with larger samples are 
needed aiming identify the role of cardiac mechanics in myocardial recovery and provide 
mechanistic insights, following cardiac unloading with an LVAD.
Conclusion
The interesting observation of myocardial recovery in a subset of mechanically unloaded 
advanced heart population is desirable and should be further pursued as a therapeutic 
strategy. The application of criteria for early identification, before LVAD implantation, of the 
population prone to a favorable response could result in enhancement of myocardial 
recovery by intensifying the anti-remodeling medication regimen and also to closely monitor 
the cardiac function with serial imaging. In the current pilot study, cardiac rotational 
mechanics before LVAD implantation identified a population prone to myocardial recovery 
following cardiac mechanical support. Notably, the recovered group of patients compared to 
the non-recovered group had similarly reduced pre-LVAD LVEF. Further study of cardiac 
rotational mechanics in LVAD supported HF patients are needed to confirm the results of the 
present study and potentially provide an additional guiding tool for LVAD explantation in 
patients with recovered myocardial function.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Clinical Perspective
Rotational and deformational parameters of the left ventricular function can provide 
additional to left ventricle ejection fraction information on the damage of a failing heart. 
Furthermore, left ventricle rotational mechanics can play the role of prognosticator for 
myocardial recovery following mechanical unloading with a left ventricular assist device. 
This piece of information is particularly important in an era characterized by an 
imbalance between the number of heart donors and recipients. The potential early 
identification of a patient with heart failure undergoing mechanical unloading with a left 
ventricular assist device could further maximize his/her anti-remodeling medication and 
make a patient’s follow up monitoring closer as a strategy for left ventricular remodeling 
identification. Future studies should explore the mechanisms underlying the differences 
in cardiac rotational and deformational mechanisms in advanced heart failure patients and 
how these parameters are affected by mechanical unloading in context with myocardial 
recovery.
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Figure 1. Flow diagram of patients included in the study
pts: patients
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Figure 2. LV twist curves
LV rotational mechanics curves derived before LVAD implantation from a patient that 
developed post-LVAD myocardial recovery (A) and from a patient that did not develop 
myocardial recovery (B). Patient (A) has LV twist of 5.1°. Patient (B), in contrast to patient 
A, reveals a clockwise rotation of the apex (the apical rotation is negative instead of 
positive). This results in both the base and the apex rotating to the same direction during 
cardiac systole and to practically zero LV twist.
LV: Left Ventricle, LVAD: Left Ventricular Assist Device, LVEF: Left Ventricle Ejection 
Fraction
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Figure 3. Time course of left ventricular ejection fraction changes following LVAD implantation
Time course of left ventricle ejection fraction following LVAD implantation in recovery and 
non-recovery group of patients.
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Figure 4. Correlation between peak LV torsion before LVAD implantation and end systolic 
volume indexed following LVAD implantation
(r=0.605, p=001)
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Figure 5. Receiver–operator characteristics curve
Receiver–operator characteristics curve, testing the accuracy of peak LV torsion, before 
LVAD implantation, to predict myocardial recovery following LVAD support. Peak LV 
torsion ≥ 0.35 °/cm had a 92% sensitivity and a 74% specificity to predict LV myocardial 
recovery.
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Figure 6. Role of cardiac rotational mechanics in predicting myocardial recovery following 
LVAD-induced mechanical unloading
Two groups of advanced HF patients presenting with similarly low LVEF had differential 
left ventricular rotational mechanics at the pre-LVAD implantation time point. Only the 
group with partially preserved rotational mechanics responded favorably following LVAD-
induced mechanical unloading with a significant increase in its LVEF. Left ventricular 
rotational mechanics can provide prognostic insights and improve patient selection for 
cardiac recovery before LVAD implantation.
HF: Heart Failure, LV: Left Ventricle, LVAD: Left Ventricular Assist Device, LVEF: Left 
Ventricular Ejection Fraction
Bonios et al. Page 20
Circ Cardiovasc Imaging. Author manuscript; available in PMC 2019 April 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Bonios et al. Page 21
Table 1
Baseline clinical and echocardiographic characteristics of control subjects and heart failure patients (before 
LVAD implantation)
Control subjects (n=15) Heart Failure patients
(n=63)
p
Age, (years) 51 ± 7 52 ± 15 0.72
Males (n, %) 5 (33.3%) 46 (74.0%) 0.28
BSA 2.0 ± 0.2 2.0 ± 0.2 0.76
Weight (kg) 91 ± 22 83 ± 18 0.16
Diabetes mellitus (n, %) 1 (6.7%) 9 (14.3%) 0.76
Hypertension (n, %) 2 (13.3%) 15 (23.8%) 0.77
LVEF, (%) 65 ± 6 18 ± 7 <0.001
LVEDV (ml) 95 ± 17 269 ± 84 <0.001
LVESV (ml) 30 ± 9 216 ± 74 <0.001
RVEDD (cm) 3.7 ± 0.4 5.0 ± 1.2 0.002
Diastolic Filling Pattern <0.001
Normal (%) 70 0
Delayed relaxation (%) 30 1
Pseudonormal (%) 0 24
Restrictive (%) 0 75
Peak LV Circumferential strain (%) −24.8 ± 4.9 −4.9 ± 3.5 <0.001
Peak LV Longitudinal Strain (%) −18.1 ± 2.6 −3.8 ± 3.1 <0.001
Peak LV basal rotation, ° −7.4 ± 3.0 −1.5 ± 2.9 <0.001
Peak LV apical rotation, ° 8.4 ± 2.9 0.7 ± 2.7 <0.001
Peak LV rotation, ° 15.6 ± 3.0 2.2 ± 3.2 <0.001
Peak LV torsion, °/cm 1.94 ± 0.45 0.25 ± 0.36 <0.001
BSA: Body Surface Area, LV: Left Ventricle, LVEF: Left Ventricle Ejection Fraction, LVEDV: Left Ventricle End-Diastolic Volume, LVESV: Left 
Ventricle End-Systolic Volume, RVEDD: Right Ventricle End-Diastolic Diameter
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Table 2
Univariate and multiple linear regression analysis to determine the independent correlates to peak left 
ventricular torsion before LVAD implantation
Univariate Multivariate
B p value β p value
Age 0.01 0.68 … …
Heart Failure symptoms duration −0.027 0.026 −0.011 0.55
LVEF 0.008 0.23 … …
Peak LV CS −0.047 0.010 −0.007 0.72
Peak LV LS −0.047 0.003 −0.040 0.14
LVEDD −0.137 0.004 −0.164 0.029
LVESV 0.001 0.20 … …
LVEDV 0.001 0.11 … …
CS: Circumferential Strain, LS: Longitudinal strain, LV: Left Ventricle, LVEDD: Left Ventricle End-Diastolic Diameter, LVEF: Left Ventricle 
Ejection Fraction, LVEDV: Left Ventricle End-Diastolic Volume, LVESV: Left Ventricle End-Systolic Volume
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Table 4
Baseline characteristics of the Recovery (Rec) and Non-Recovery (Non-Rec) Groups
Rec Group (n=12) Non-Rec Group (n=51) p
Age, (years) 38 ± 19 53 ± 16 0.007
Male (n) 8 38 0.582
BSA 1.89 ± 0.1 2.00 ± 0.25 0.13
Weight 85 ± 19 78 ± 10 0.26
Duration of HF Symptoms, (years) 1.8 ± 1.0 6.1 ± 4.1 0.03
Etiology of HF (Ischemic/non-ischemic) 1/11 19/32 0.06
Inotropic therapy (%) 50 59 0.56
Diabetes mellitus (%) 0 19 0.10
Hypertension (%) 30 26 0.80
Beta blocker (%) 83 77 0.66
ACE-i/ARB (%) 67 68 0.93
ICD/CRT 83 92 0.70
LVAD type 0.83
Heartware (%) 15 18
Heartmate (%) 75 63
VentrAssist (%) 0 2
Jarvik (%) 10 17
Indication of LVAD 0.22
Destination therapy (%) 8 32
Bridge to transplant (%) 84 57
Bridge to decision (%) 8 11
Follow up (months) 7.6 ± 3.8 7.3 ± 3.7 0.85
Creatinine (mh/dl) 1.2 ± 0.4 1.3± 0.4 0.22
BUN (mg/dl) 34 ± 25 23 ± 16 0.79
Hb (g/dl) 12.8 ± 2.0 13.1± 2.1 0.78
BNP (pg/L) 1922 ± 1392 1552 ± 919 0.39
Na (meq/L) 133 ± 4 134 ± 6 0.59
T-bilirubin (ng/dl) 1.47 ± 0.92 1.42 ± 0.84 0.88
Right Heart Catheterization Parameters
Systemic Systolic BP, mmHg 97 ± 18 100 ± 8 0.74
Systemic Diastolic BP mmHg 67 ± 11 66 ± 14 0.55
RAP, mmHg 9 ± 8 10 ± 6 0.67
Mean PAP, mmHg 37 ± 9 38 ± 8 0.29
PCWP, mmHg 24 ± 10 25 ± 7 0.76
CI, L/min/m2 2.24 ± 0.85 1.73±0.40 0.004
PVR, woods 2.00 ± 0.67 4.77 ± 2.94 0.08
BNP: Brain Natriuretic Peptide, BP: Blood Pressure, BSA: Body Surface Area, BUN: Blood Urea Nitrogen, CI: Cardiac Index, Hb: Hemoglobin, 
ICD/CRT: Implantable Cardiac Defibrillator/Cardiac Resynchronization Therapy, LVAD: Left Ventricular Assist Device, Na: Serum Sodium, 
PCWP: Pulmonary Capillary Wedge Pressure, PVR: Pulmonary Vascular Resistances RAP: Right Atrial Pressure, T-billirubin: Total-billirubin
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Table 6
Baseline Rotational and Deformational Echocardiographic Parameters
Rec Group
(n=12)
Non-Rec Group
(n=51)
p
Apical rotation, (°) 1.49 ± 3.3 0.5 ± 2.59 0.27
Basal rotation, (°) −3.44 ± 2.98 −1.05 ± 2.71 0.009
Abnormal rotation direction (base or apex) (n) 3 35 0.004
Left ventricle twist, (°) 4.87 ± 1.67 1.60 ± 3.16 0.001
Left ventricle torsion, (°/cm) 0.56 ± 0.24 0.17 ± 0.34 0.001
Left ventricle longitudinal strain, (%) −4.9 ± 3.8 −3.5 ± 2.87 0.14
Left ventricle circumferential strain, (%) −6.38 ± 5.44 −4.31 ± 2.70 0.12
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Table 7
Univariate and Multivariable Logistic Regression Analysis To Determine Independent Predictors of LV 
Recovery Following LVAD Support. Odds ratios (OR)>1.0 indicate the odds of not recovering, thus OR<1.0 
provides the relative odds of recovery.
Univariate Bivariable
OR
(95% CI)
p
value
OR
(95% CI)
p
value
Heart Failure Symptoms Duration 1.65 (1.13 – 2.41) 0.010 ----- -----
Cardiac Index 0.20 per L/min/m2 (0.06 – 0.78) 0.020 ----- -----
Peak LV Torsion 0.65 per 0.1 °/cm (0.49 – 0.87) 0.014 ----- -----
Age 1.66 per decade (1.12, 2.48) 0.012 ----- -----
Bivariable Models
Heart Failure Symptoms Duration ----- ----- 1.67 (1.00, 2.49) 0.027
Peak LV Torsion ----- ----- 0.63 per 0.1 °/cm (0.42, 0.94) 0.009
Cardiac Index ----- ----- 0.26 per L/min/m2 (0.06, 1.14) 0.26
Peak LV Torsion ----- ----- 0.67 per 0.1 °/cm (0.50, 0.91) 0.019
Age ----- ----- 1.77 per decade (1.13, 2.74) 0.013
Peak LV Torsion ----- ----- 0.64 per 0.1 °/cm (0.50, 0.88) 0.005
LV: left Ventricle
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